Visoltricin, a novel biologically active compound produced by Fusarium tricinctum

Abstract

The major compound responsible for toxicity to Artemia salina of some Fusarium tricinctum strains has been isolated, and its structure has been elucidated by spectroscopical methods, i.e. UV, IR, MS, ¹H‐NMR and ¹³C‐NMR. The novel compound, trivially named visoltricin, is the first imidazole derivative produced by Fusarium spp., and its structure has been established as the methyl ester of 3‐[l‐methyl‐4‐(3‐methyl‐2‐butenyl)‐imidazol‐5yl]‐2‐propenoic acid (molecular formula C₁₃H₁₈N₂O₂; MW = 234.297). Visoltricin was toxic to A. salina larvae (LD₅₀ = 8.5 × 10‐⁷M), and inhibited the growth of six human tumour cell lines (out of 60 lines tested) at concentrations lower than ^10–5M. Tested on rabbit eye it showed an interesting miotic activity similar to that of pilocarpine, a miotic agent largely used in the therapy of glaucoma. This biological activity could be explained in part by the anticholinesterase properties shown by visoltricin towards both human serum and pure enzymes (EC 3.1.1.7 and EC 3.1.1.8). Kinetics studies showed for visoltricin a mixed‐type and reversible inhibition of the EC 3.1.1.7 enzyme with the competitive inhibition constant (Ki) = l.9×10⁻⁴M.

Keywords:

• Fusarium
• imidazole
• anticholinesterase
• miotic activity
• visoltricin